Arianna Zangrilli

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Topics

Hidradenitis Suppurativa

Top Venues

Dermatologic therapy

International journal of molecular sciences

The Journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini, Mauro Bavetta, Clara De Simone, Dario Graceffa, Claudio Bonifati, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Richetta, Ketty Peris, Luca Bianchi
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study. Dermatologic therapy 35 (6) (2022)
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, Mauro Bavetta, Dario Graceffa, Claudio Bonifati, Franca Cantoresi, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Federico Pirro, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Giovanni Richetta, Lidia Sacchelli, Luca Bianchi, Ketty Peris
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy. Expert opinion on biological therapy 21 (9) (2021)
Chiara Pensa, Arianna Piccolo, Arianna Zangrilli, Mauro Bavetta, Luca Bianchi
Risankizumab: How to choose the right dose in clinical practice? Dermatologic therapy 33 (6) (2020)
Arianna Piccolo, Chiara Pensa, Arianna Zangrilli, Mauro Bavetta, Augusto Orlandi, Luca Bianchi
Ixekizumab: One drug for an enigmatic psoriasis. Dermatologic therapy 33 (6) (2020)
Laura Diluvio, Laura Vollono, Arianna Zangrilli, Valeria Manfreda, Monia Di Prete, Antonio Massaro, Stella Modica, Elisabetta Greco, Luca Bianchi, Elena Campione
Omalizumab and adalimumab: a winning couple. Immunotherapy 12 (18) (2020)
Arianna Piccolo, Chiara Pensa, Arianna Zangrilli, Mauro Bavetta, Laura Diluvio, Luca Bianchi
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: Case report. Dermatologic therapy 33 (6) (2020)
Caterina Lanna, Arianna Zangrilli, Mauro Bavetta, Elena Campione, Luca Bianchi
Efficacy and safety of adalimumab in difficult-to-treat psoriasis. Dermatologic therapy 33 (3) (2020)
Sara Mazzilli, Caterina Lanna, Carlo Chiaramonte, Gaia Maria Cesaroni, Arianna Zangrilli, Vincenzo Palumbo, Terenzio Cosio, Annunziata Dattola, Roberta Gaziano, Marco Galluzzo, Maria Sole Chimenti, Paolo Gisondi, Luca Bianchi, Elena Campione
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers. The Journal of dermatology 47 (6) (2020)
Agostino Bucalo, Federica Rega, Arianna Zangrilli, Valentina Silvestri, Virginia Valentini, Giorgia Scafetta, Federica Marraffa, Sara Grassi, Elena Rogante, Arianna Piccolo, Salvatore Cucchiara, Franca Viola, Luca Bianchi, Laura Ottini, Antonio Richetta
Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers. International journal of molecular sciences 21 (21) (2020)
Caterina Lanna, Sara Mazzilli, Arianna Zangrilli, Luca Bianchi, Elena Campione
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast. Dermatologic therapy 32 (6) (2019)
Arianna Zangrilli, Mauro Bavetta, Sara Mazzilli, Virginia Garofalo, Luca Bianchi
Paradoxical case effects of psoriasis following adalimumab therapy: A case series. Dermatologic therapy 31 (6) (2018)